Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!
How Rapidly is the Crohn’s Disease (CD) Treatment Market Expected to Expand Between 2025 and 2034 Based on Current Trends?
The market size for treatment of Crohn’s Disease (CD) has seen significant growth in the past few years. The size is expected to escalate from $11.76 billion in 2024 to $12.38 billion in 2025, exhibiting a 5.3% compound annual growth rate (CAGR). The remarkable growth observed in the historical period can be credited to the increasing occurrences of Crohn’s disease, heightened consciousness about the condition, government efforts, and lifestyle changes.
In the coming years, the market for Crohn’s disease (CD) treatment is projected to experience impressive growth, to reach $15.06 billion in 2029, with a compound annual growth rate (CAGR) of 5.0%. This growth during the forecast period can be attributed to the rising demand for combination therapies, the growing use of biologics, and increased investment in research and development for Crohn’s disease treatments. Some of the major trends expected during this period include the development of biologic drugs, the creation of innovative products, the use of advanced diagnostic tools, and the adoption of biosimilars.
Which Primary Drivers Are Supporting the Continued Expansion of the crohn’s disease (cd) treatment Market?
The Crohn’s disease (CD) treatment market is set to witness accelerated growth due to the escalating prevalence of inflammatory bowel diseases. Inflammatory bowel disease (IBD) is a collection of chronic inflammatory conditions primarily impacting the gastrointestinal (GI) tract. The treatment for Crohn’s disease (CD) provides symptom relief, inflammation reduction, promotion of remission, and enhancement of overall quality of life for those affected by chronic inflammatory bowel disease. For instance, in September 2023, the United States National Library of Medicine, a medical library in the US, cited that Canada’s incidence of inflammatory bowel diseases (IBD) was estimated to be at 30 per 100,000 person years in 2023, with a projected steady rise of about 0.58% annually. In 2023, Canada’s IBD prevalence hit around 825 per 100,000, with predictions indicating a potential rise to 1.1% of the population by 2035. As a result, the rising incidence of inflammatory bowel diseases is a key driver of the Crohn’s disease (CD) treatment market.
Driving the Crohn’s Disease (CD) Treatment Market: Increased Clinical Trials Contribute to its Expansion
Explore Comprehensive Insights Into The Global Crohn’s Disease (CD) Treatment Market With A Free Sample Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12902&type=smp
Which Key Players Are Shaping the Future of the Crohn’s Disease (CD) Treatment Market?
Major companies operating in the crohn’s disease (cd) treatment market are:
• Pfizer Inc._x000D_
• Johnson and Johnson Ltd._x000D_
• Merck and Co. Inc._x000D_
• AbbVie Inc._x000D_
• Novartis AG_x000D_
How Are the Latest Trends Influencing the Growth of the Crohn’s Disease (CD) Treatment Market?
Key players in the Crohn’s disease (CD) treatment market are innovating by launching new technologies like IBDSENSE to maintain their market stance. For example, The IRR Chemistry Hub, an interdisciplinary hub based in Scotland, rolled out IBDSENSE in March 2023. This technology focuses on enhancing the diagnosis and monitoring of inflammatory bowel diseases using non-invasive methodologies, amongst which Crohn’s disease is included. The initiative leverages fluorescence-based technology for the measurement of Granzyme B (GzmB) enzyme activity in patient biosamples. The objective of this technology is to elevate patient experiences and diversify treatment options.
Secure Your Global Crohn’s Disease (CD) Treatment Market Report Now for Fast and Efficient Delivery!
https://www.thebusinessresearchcompany.com/report/crohns-disease-cd-treatment-global-market-report
What Are the Core Segments of the Crohn’s Disease (CD) Treatment Market, and How Do They Contribute to Growth?
The crohn’s disease (CD) treatment market covered in this report is segmented –
1) By Drug Type: Antibiotics, Amino Salicylates, Corticosteroids, Immunomodulators, Other Drug Types
2) By Route of Administration: Oral, Injectable
3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Drug Stores
Subsegments:
1) By Antibiotics: Metronidazole, Ciprofloxacin, Rifaximin
2) By Amino Salicylates: Mesalamine, Sulfasalazine
3) By Corticosteroids: Prednisone, Budesonide, Hydrocortisone
4) By Immunomodulators: Azathioprine, Mercaptopurine, Methotrexate
5) By Other Drug Types: Biologic Therapies, Janus Kinase Inhibitors, Small Molecules
What Regions Are At the Forefront of Crohn’s Disease (CD) Treatment Market Expansion?
North America was the largest region in the Crohn’s disease (CD) treatment market in 2024. The regions covered in Crohn’s disease (CD) treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
How Is the Crohn’s Disease (CD) Treatment Market Classified and Defined in Market Analysis?
Crohn’s disease (CD) is an inflammatory bowel disease (IBD) that causes inflammation and swelling of the tissues in the digestive tract. Crohn’s disease (CD) treatment involves various approaches, therapies, medications and interventions to manage and control the symptoms and complications of a chronic inflammatory condition.
Browse Through More Similar Reports By The Business Research Company:
Gastric Cancer Drugs Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/gastric-cancer-drugs-global-market-report
Gastric Volvulus Treatment Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/gastric-volvulus-treatment-global-market-report
Irritable Bowel Syndrome (IBS) Treatment Global Market Report 2024
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on: